Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Jacques Patard

Showing results (31-40 of 247) with videos related to

Pageof 25
Sort By:
World Journal of Urology|February 13, 2008
Targeted therapy in renal cell carcinomaJean-Jacques Patard, Damien Pouessel, Karim Bensalah, et al.
Bulletin Du Cancer|March 31, 2015
[Management of side effects of targeted therapies in renal cancer: iatrogenic side effects]Christophe Massard, Jean-Jacques Patard, Olivier Hermine, et al.
Expert Review of Anticancer Therapy|November 26, 2011
Optimizing treatment for metastatic renal cell carcinomaJean-Jacques Patard, Camillo Porta, John Wagstaff, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 1, 2002
[Mumps virus and orchitis: towards a physiopathologic approach]Thomas Mouchel, Ronan Le Goffic, Jean-Jacques Patard, et al.
Current Opinion in Urology|June 3, 2014
Relationship between surgical volume and outcomes in nephron-sparing surgeryBenoit Peyronnet, Jean-Philippe Couapel, Jean-Jacques Patard, et al.
European Urology|February 6, 2007
Rebuttal from authors re: Edward M. Messing. Node positive renal cell cancer. Who can be helped? Eur Urol 2007;51:1477-8Pierre Karakiewicz, Paul Perrotte, Quoc-Dien Trinh, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 8, 2006
[Risks and benefits of total nephrectomy in elderly patients over the age of 80]Karim Bensalah, Adil Sadiq, François Guillé, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 8, 2006
[Follow-up of renal cancer. Guidelines of the Comité de Cancérologie de l'Association Française d'Urologie]Jean-Philippe Fendler, Jean-Jacques Patard, Arnaud Mejean, et al.
Archivos Espanoles De Urologia|November 25, 2010
Tyrosine-kinase inhibitors in the treatment of muscle invasive bladder cancer and hormone refractory prostate cancerHervé Wallerand, Grégoire Robert, Jean-Christophe Bernhard, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 11, 2007
[Is tumour expression of VEGF associated with venous invasion and survival in pT3 renal cell carcinoma?]Karim Bensalah, Nathalie Rioux-Leclercq, Sébastien Vincendeau, et al.
Pageof 25

Showing results (31-40 of 247) with videos related to

Sort By:
Pageof 25
World Journal of Urology|February 13, 2008
Targeted therapy in renal cell carcinomaJean-Jacques Patard, Damien Pouessel, Karim Bensalah, et al.
Bulletin Du Cancer|March 31, 2015
[Management of side effects of targeted therapies in renal cancer: iatrogenic side effects]Christophe Massard, Jean-Jacques Patard, Olivier Hermine, et al.
Expert Review of Anticancer Therapy|November 26, 2011
Optimizing treatment for metastatic renal cell carcinomaJean-Jacques Patard, Camillo Porta, John Wagstaff, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 1, 2002
[Mumps virus and orchitis: towards a physiopathologic approach]Thomas Mouchel, Ronan Le Goffic, Jean-Jacques Patard, et al.
Current Opinion in Urology|June 3, 2014
Relationship between surgical volume and outcomes in nephron-sparing surgeryBenoit Peyronnet, Jean-Philippe Couapel, Jean-Jacques Patard, et al.
European Urology|February 6, 2007
Rebuttal from authors re: Edward M. Messing. Node positive renal cell cancer. Who can be helped? Eur Urol 2007;51:1477-8Pierre Karakiewicz, Paul Perrotte, Quoc-Dien Trinh, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 8, 2006
[Risks and benefits of total nephrectomy in elderly patients over the age of 80]Karim Bensalah, Adil Sadiq, François Guillé, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 8, 2006
[Follow-up of renal cancer. Guidelines of the Comité de Cancérologie de l'Association Française d'Urologie]Jean-Philippe Fendler, Jean-Jacques Patard, Arnaud Mejean, et al.
Archivos Espanoles De Urologia|November 25, 2010
Tyrosine-kinase inhibitors in the treatment of muscle invasive bladder cancer and hormone refractory prostate cancerHervé Wallerand, Grégoire Robert, Jean-Christophe Bernhard, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 11, 2007
[Is tumour expression of VEGF associated with venous invasion and survival in pT3 renal cell carcinoma?]Karim Bensalah, Nathalie Rioux-Leclercq, Sébastien Vincendeau, et al.
Pageof 25